Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1151-1152

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edgington, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edgington, T.

(Circulation. 1998;98:1151-1152.)
© 1998 American Heart Association, Inc.


Editorial

More Cellular Signals for Atherogenesis?

Thomas Edgington, MD

From the Departments of Immunology and Vascular Biology, The Scripps Research Institute, La Jolla, Calif.

Correspondence to Thomas Edgington, MD, Departments of Immunology and Vascular Biology, The Scripps Research Institute, 10550 N Torrey Pines Rd, La Jolla, CA 92037. E-mail tse@scripps.edu


Key Words: Editorials • atherogenesis • genes • lesion

The potential importance of the nuclear factor {kappa}B (NF-{kappa}B) system as a key player in control of transcription of genes for mediators of a variety of inflammatory responses, from those mediated by cytokine pathways to atherogenesis and thrombogenesis, has been a topic of broad interest. The proteins of the NF-{kappa}B family that form the inactive heterodimeric complexes in the cytoplasm of cells, the inhibitors that prevent nuclear translocation, and the stimuli that lead to release and nuclear translocation of the active uninhibited NF-{kappa}B complexes, commonly referred to as activation, have received great attention, as have the many genes subject to transcriptional activation by the various heterodimeric NF-{kappa}B complexes once translocated to the nucleus. These details are central to the goal of mapping the cellular and molecular pathways of vascular injury, including atherosclerosis, restenosis, and other vascular pathobiology. The overall schema is growing richer in detail and interpretive hypotheses. However, the answers remain elusive. A valid schema is nevertheless critically important to discovery of molecular strategies for effective and safe intervention in acute and chronic diseases of the vasculature.

In the present issue of Circulation, Gawaz and colleagues1 advance our understanding of a cellular and molecular scenario most likely operative in the vascular pathology early in the atherogenic cascade and perhaps pertaining as well to the local activation of the thrombogenic cascade, as in unstable angina.

In brief, this study addresses changes of gene transcription and gene product expression of the endothelial cell resulting from the . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Hattori, M. Matsumura, and K. Kasai
Vascular smooth muscle cell activation by C-reactive protein
Cardiovasc Res, April 1, 2003; 58(1): 186 - 195.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
F. C. Visser
Prediction of Surgical Treatment Effect by Preoperative Imaging:Present and Future Perspectives
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 31 - 36.
[PDF]


Home page
HypertensionHome page
Y. Hattori, M. Suzuki, S. Hattori, and K. Kasai
Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts)
Hypertension, January 1, 2002; 39(1): 22 - 28.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al.
Reply
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1272 - 1273.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Adamopoulos, J. T. Parissis, and D. Th. Kremastinos
A glossary of circulating cytokines in chronic heart failure
Eur J Heart Fail, October 1, 2001; 3(5): 517 - 526.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-C. Bourdillon, R. N. Poston, C. Covacho, E. Chignier, G. Bricca, and J. L. McGregor
ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE-/-/ICAM-1-/-) Fed a Fat or a Chow Diet
Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2630 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Zibara, E. Chignier, C. Covacho, R. Poston, G. Canard, P. Hardy, and J. McGregor
Modulation of Expression of Endothelial Intercellular Adhesion Molecule-1, Platelet-Endothelial Cell Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Aortic Arch Lesions of Apolipoprotein E-Deficient Compared With Wild-Type Mice
Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2288 - 2296.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Hattori, S. Hattori, N. Sato, and K. Kasai
High-glucose-induced nuclear factor {kappa}B activation in vascular smooth muscle cells
Cardiovasc Res, April 1, 2000; 46(1): 188 - 197.
[Abstract] [Full Text] [PDF]